The preparation and clinical use of a new concentrate containing factor IX, prothrombin and factor X and of a separate concentrate containing factor VII

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation.

Lancet (London, England)·1997

Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. UK Haemophilia Centre Directors' Organisation.

Lancet (London, England)·1996

Mortality before and after HIV infection in the complete UK population of haemophiliacs. UK Haemophilia Centre Directors' Organisation.

Nature·1995

Low risk of sexual transmission of hepatitis C virus.

Journal of medical virology·1993

Confirmation of viral safety of dry heated factor VIII concentrate (8Y) prepared by Bio Products Laboratory (BPL): a report on behalf of U.K. Haemophilia Centre Directors.

British journal of haematology·1993

Analysis of factor VIII mRNA reveals defects in everyone of 28 haemophilia A patients.

Human molecular genetics·1993

Temporal trends in infectious risk among multiple myeloma patients treated with daratumumab: A meta-analysis.

British journal of haematology·2026

The speed of sequencing: Rapid molecular testing in acute myeloid leukaemia.

British journal of haematology·2026

Whole-genome and transcriptome analysis in relapsed/refractory non-Hodgkin lymphoma: Results from a multicentre precision oncology cohort.

British journal of haematology·2026

Temporal lobe cortical thickness and cognition in paediatric cancer survivors previously treated with chemotherapy.

British journal of haematology·2026

The genomic and transcriptomic landscape of chronic lymphocytic leukaemia: Insights from an integrated analysis of 275 patients.

British journal of haematology·2026

Ibrutinib and standard immunochemotherapy in younger, high-risk patients with diffuse large B-cell lymphoma: A phase II study of GLA.

British journal of haematology·2026

Recombinant activated factor VIIa for severe postpartum hemorrhage in Africa: Evidence, appropriate use, and research priorities-A narrative review.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026

Circulating Biomarkers Associated With Hereditary Hemorrhagic Telangiectasia Sensitive to ALK1 Modulation.

American journal of hematology·2026

Blocking FcγRI and FcγRIII reduces RBC phagocytosis induced by patient-derived anti-E and anti-K alloantibodies in vitro.

Transfusion·2026

Massive Splenomegaly in an Adult With a Hemoglobin Fractionation Pattern Suggestive of Hereditary Persistence of Fetal Hemoglobin: A Case Report.

Cureus·2026

A novel Hemoglobin-Albumin-Lymphocyte-Platelet (HALP)-based prognostic model to predict the progression of premenopausal breast cancer: a retrospective cohort study.

BMC cancer·2026

EXPRESS: Brain on fire: Why intracerebral hemorrhage requires a firefighting strategy beyond single therapeutic targets.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026

Related Experiment Videos

The preparation and clinical use of a new concentrate containing factor IX, prothrombin and factor X and of a

Related Concept Videos

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation.

Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. UK Haemophilia Centre Directors' Organisation.

Mortality before and after HIV infection in the complete UK population of haemophiliacs. UK Haemophilia Centre Directors' Organisation.

Low risk of sexual transmission of hepatitis C virus.

Confirmation of viral safety of dry heated factor VIII concentrate (8Y) prepared by Bio Products Laboratory (BPL): a report on behalf of U.K. Haemophilia Centre Directors.

Analysis of factor VIII mRNA reveals defects in everyone of 28 haemophilia A patients.

Temporal trends in infectious risk among multiple myeloma patients treated with daratumumab: A meta-analysis.

The speed of sequencing: Rapid molecular testing in acute myeloid leukaemia.

Whole-genome and transcriptome analysis in relapsed/refractory non-Hodgkin lymphoma: Results from a multicentre precision oncology cohort.

Temporal lobe cortical thickness and cognition in paediatric cancer survivors previously treated with chemotherapy.

The genomic and transcriptomic landscape of chronic lymphocytic leukaemia: Insights from an integrated analysis of 275 patients.

Ibrutinib and standard immunochemotherapy in younger, high-risk patients with diffuse large B-cell lymphoma: A phase II study of GLA.

Recombinant activated factor VIIa for severe postpartum hemorrhage in Africa: Evidence, appropriate use, and research priorities-A narrative review.

Circulating Biomarkers Associated With Hereditary Hemorrhagic Telangiectasia Sensitive to ALK1 Modulation.

Blocking FcγRI and FcγRIII reduces RBC phagocytosis induced by patient-derived anti-E and anti-K alloantibodies in vitro.

Massive Splenomegaly in an Adult With a Hemoglobin Fractionation Pattern Suggestive of Hereditary Persistence of Fetal Hemoglobin: A Case Report.

A novel Hemoglobin-Albumin-Lymphocyte-Platelet (HALP)-based prognostic model to predict the progression of premenopausal breast cancer: a retrospective cohort study.

EXPRESS: Brain on fire: Why intracerebral hemorrhage requires a firefighting strategy beyond single therapeutic targets.

Related Experiment Videos

The preparation and clinical use of a new concentrate containing factor IX, prothrombin and factor X and of a...

Related Concept Videos

Related Articles

The preparation and clinical use of a new concentrate containing factor IX, prothrombin and factor X and of a